1. The proof of efficacy in psychopharmacology: clinical studies, metaanalysis and evidence-based medicine

   • Siegfried Kasper

   Special Issue - Editorial 17 October 2009 Pages: 1 - 1

2. Principle standards and problems regarding proof of efficacy in clinical psychopharmacology

   • Hans-Jürgen Möller
   • Karl Broich

   Special Issue 04 November 2009 Pages: 3 - 16

   

3. Meta-analyses: a method to maximise the evidence from clinical studies?

   • Wolfgang Maier
   • Hans-Jürgen Möller

   Special Issue 26 November 2009 Pages: 17 - 23

4. Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations

   • Hans-Jürgen Möller
   • Wolfgang Maier

   Special Issue 17 October 2009 Pages: 25 - 39

5. Metabolic syndrome: a follow-up study of acute depressive inpatients

   • N. Richter
   • G. Juckel
   • H.-J. Assion

   Original Paper 28 April 2009 Pages: 41 - 49

   

6. Improving outpatient treatment in schizophrenia: effects of computerized guideline implementation—results of a multicenter-study within the German Research Network on Schizophrenia

   • B. Janssen
   • S. Ludwig
   • W. Gaebel

   Original Paper 12 May 2009 Pages: 51 - 57

   

7. The European Post-marketing Observational Sertindole Study: an investigation of the safety of antipsychotic drug treatment

   • Siegfried Kasper
   • Hans-Jürgen Möller
   • Anthony Hale

   Original Paper 20 May 2009 Pages: 59 - 68

8. ¹⁸FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia

   • Emilio Fernandez-Egea
   • Eduard Parellada
   • Miguel Bernardo

   Original Paper 19 May 2009 Pages: 69 - 76

   

9. Neuregulin-1 genotypes and eye movements in schizophrenia

   • H. Magnus Haraldsson
   • Ulrich Ettinger
   • Hannes Petursson

   Original Paper 03 July 2009 Pages: 77 - 85